SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 4 - Statement of changes in beneficial ownership of securities:
SEC Accession No. 0001209191-19-031833
Filing Date
2019-05-21
Accepted
2019-05-21 18:27:22
Documents
1
Period of Report
2019-05-17

Document Format Files

Seq Description Document Type Size
1 FORM 4 SUBMISSION doc4.html 4  
1 FORM 4 SUBMISSION doc4.xml 4 9108
  Complete submission text file 0001209191-19-031833.txt   10673
Mailing Address 1 GREAT VALLEY PARKWAY SUITE 30 MALVERN PA 19355
Business Address 1 GREAT VALLEY PARKWAY SUITE 30 MALVERN PA 19355 (610) 981-6500
PhaseBio Pharmaceuticals Inc (Issuer) CIK: 0001169245 (see all company filings)

IRS No.: 030375697 | State of Incorp.: DE | Fiscal Year End: 1231
SIC: 2834 Pharmaceutical Preparations

Mailing Address 2025 1ST AVENUE SUITE 800 SEATTLE WA 98121
Business Address
Mow Jonathan P (Reporting) CIK: 0001313942 (see all company filings)

Type: 4 | Act: 34 | File No.: 001-38697 | Film No.: 19843600